Sunshine Biopharma, Inc.
SBFM
$1.25
$0.032.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.55% | -35.23% | -41.67% | -9.64% | -25.36% |
| Total Receivables | 51.56% | 58.24% | 97.56% | 57.93% | 33.48% |
| Inventory | 96.66% | 117.42% | 99.74% | 107.49% | 74.32% |
| Prepaid Expenses | 264.87% | 1,856.91% | 1,560.28% | 472.16% | 9.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.32% | 2.15% | -1.34% | 15.57% | -8.87% |
|
|
|||||
| Total Current Assets | 4.32% | 2.15% | -1.34% | 15.57% | -8.87% |
| Net Property, Plant & Equipment | 46.37% | 13.32% | 2.56% | -8.60% | -12.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 109.08% | 141.96% | 98.37% | 117.84% | 85.91% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.75% | 8.70% | 3.14% | 18.18% | -6.49% |
|
|
|||||
| Total Accounts Payable | 114.39% | 87.19% | 180.15% | 32.12% | -7.75% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 75.06% | -1.27% | -6.22% | -4.86% | -3.50% |
| Total Finance Division Other Current Liabilities | -80.19% | -90.73% | -90.82% | -30.76% | -28.90% |
| Total Other Current Liabilities | -80.19% | -90.73% | -90.82% | -30.76% | -28.90% |
| Total Current Liabilities | 13.75% | -11.00% | 13.72% | -5.39% | -19.90% |
|
|
|||||
| Total Current Liabilities | 13.75% | -11.00% | 13.72% | -5.39% | -19.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.16% | -20.77% | -22.45% | -18.94% | -16.07% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 13.26% | 13.26% | 13.26% | 13.26% |
| Total Liabilities | 14.98% | -11.77% | 9.64% | -6.38% | -19.39% |
|
|
|||||
| Common Stock & APIC | 10.59% | 8.68% | 6.39% | 11.80% | 4.39% |
| Retained Earnings | -8.03% | -6.74% | -5.93% | -6.69% | -7.59% |
| Treasury Stock & Other | -219.24% | -17.56% | -202.71% | -11.91% | 330.22% |
| Total Common Equity | 10.76% | 13.95% | 1.59% | 27.68% | -1.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% | 0.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% | 0.00% |
|
|
|||||
| Total Common Equity | 10.76% | 13.95% | 1.59% | 27.68% | -1.94% |
| Total Preferred Equity | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.81% | 14.00% | 1.64% | 27.74% | -1.94% |
|
|
|||||